×
GreekEnglish

×
  • Politics
  • Diaspora
  • World
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Cooking
Wednesday
14
Jan 2026
weather symbol
Athens 9°C
  • Home
  • Politics
  • Economy
  • World
  • Diaspora
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Mediterranean Cooking
  • Weather
Contact follow Protothema:
Powered by Cloudevo
> World

EMA says there is no evidence for 4th Covid booster for general population

EMA also said continued vaccine boosters could reduce the level of antibodies

Newsroom January 18 07:45

The European Medicines Agency (EMA) said there was no evidence for a 4th Covid-19 vaccine. “Currently, there is no evidence for the need for a fourth dose in the general population.” Marco Cavaleri, head of vaccines of the European Medicines Agency Ema, pointed out during a video briefing with the press.

He added that repeated administration of “booster doses of the anti-Covid vaccine with very short intervals could reduce the level of antibodies that can be produced with each administration.”

“In people with severely weakened immune systems and who have already received three doses, it would be reasonable for health authorities to consider administering the fourth dose,” Cavaleri suggests. A review of EMA scientific studies also “did not find any increased risk of complications after mRNA Covid vaccine in pregnancy, spontaneous abortion, preterm birth or adverse effects in unborn babies.”

Meanwhile, preliminary research from Israel suggested that a fourth Covid-19 booster vaccine might not be useful after all.

>Related articles

Scientists’ alert on avian flu – Could cause a pandemic worse than COVID-19

Kontoaggelos to Proto Thema: “COVID-19 triggered depression, but not psychiatric drug use” – Supporting cancer patients and answering the hard questions

China’s chikungunya virus alert, over 7,000 cases – Giant mosquitoes and drones recruited

The results show that a fourth jab is ineffective against stopping Omicron infections.

‘Despite a significant increase in antibodies after the fourth vaccine, this protection is only partially effective against the Omicron strain, which is relatively resistant to the vaccine,’ explained lead researcher Gili Regev-Yochay.

 

Ask me anything

Explore related questions

#booster dose#coronavirus#COVID-19#European Medicines Agency (EMA)
> More World

Follow en.protothema.gr on Google News and be the first to know all the news

See all the latest News from Greece and the World, the moment they happen, at en.protothema.gr

> Latest Stories

What farmers gained from the meeting with Mitsotakis: The package for electricity, fuel, and income support – The message to the “hardliners” at the roadblocks

January 13, 2026

“Digital noise” from outdated technology caused chaos in the Athens FIR – What the committee’s findings say

January 13, 2026

JPMorgan: Greece one of the most attractive markets for the Emerging Europe category

January 13, 2026

Kimon arrives at Faliro as Europe’s heavily armed frigate enters Greek waters

January 13, 2026

ELSTAT: Inflation up to 2.6% in December

January 13, 2026

Spain aims to control deepfakes created with AI

January 13, 2026

Le Pen’s party’s appeal to decide her presidential future begins

January 13, 2026

Pyrgos: man attacked his wife with a knife and then threatened to kill himself

January 13, 2026
All News

> World

Spain aims to control deepfakes created with AI

The bill makes it illegal to use a person's image or voice created without consent through AI for advertising or commercial purposes

January 13, 2026

Le Pen’s party’s appeal to decide her presidential future begins

January 13, 2026

South Korea prosecutors seek death penalty for former President Yoon Suk Yeol

January 13, 2026

Parliamentary elections set for April 12 in Hungary as Orbán appears weakened in polls

January 13, 2026

Iran is preparing to execute by hanging a 26-year-old man, Erfan, for his participation in anti-government protests.

January 13, 2026
Homepage
PERSONAL DATA PROTECTION POLICY COOKIES POLICY TERM OF USE
Powered by Cloudevo
Copyright © 2026 Πρώτο Θέμα